Indeed, the attenuation of TGF-β signaling and aberrant activation of NF-κB are observed in a major subset of early premalignant lesions as well as in head and neck squamous cell carcinoma (HNSCC)16, 23. The gene discussed is TGFB1; the disease is head and neck squamous cell carcinoma.